Development of a Virosomal RSV Vaccine Containing 3D-PHAD® Adjuvant: Formulation, Composition, and Long-Term Stability

PURPOSE: Characterization of virosomes, in late stage preclinical development as vaccines for Respiratory Syncytial Virus (RSV), with a membrane-incorporated synthetic monophosphoryl lipid A, 3D-PHAD® adjuvant. METHODS: Virosomes were initially formed by contacting a lipid film containing 3D-PHAD® w...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Pharm Res
Glavni autori: Lederhofer, J., van Lent, J., Bhoelan, F., Karneva, Z., de Haan, A., Wilschut, J.C., Stegmann, T.
Format: Artigo
Jezik:Inglês
Izdano: Springer US 2018
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6061504/
https://ncbi.nlm.nih.gov/pubmed/29971500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11095-018-2453-y
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items